0001127602-19-003053.txt : 20190130
0001127602-19-003053.hdr.sgml : 20190130
20190130161045
ACCESSION NUMBER: 0001127602-19-003053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190128
FILED AS OF DATE: 20190130
DATE AS OF CHANGE: 20190130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAAB THOMAS R II
CENTRAL INDEX KEY: 0001230708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 19552064
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-01-28
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001230708
STAAB THOMAS R II
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior Vice President and CFO
Common Stock
2019-01-28
4
M
0
5000
5.45
A
133426
D
Common Stock
2019-01-28
4
S
0
5000
9.85
D
128426
D
Emp. Stock Option (Right to Buy)
5.45
2019-01-28
4
M
0
5000
0
D
2014-08-08
2023-08-08
Common Stock
5000
7000
D
The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018.
/s/ Alane P. Barnes, by power of attorney
2019-01-30